Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 426-427 [2019-00196]
Download as PDF
426
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), Subcommittee on
Procedures Review (SPR), National
Institute for Occupational Safety and
Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Procedure
Reviews (SPR) of the Advisory Board on
Radiation and Worker Health (ABRWH).
This meeting is open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the audio conference
(information below). The audio
conference line has 150 ports for callers.
DATES: The meeting will be held on
February 13, 2019, 10:30 a.m. to 3:30
p.m. EST.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30329, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:01 Jan 25, 2019
Jkt 247001
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered on February 12, 2018,
pursuant to Executive Order 13708, and
will terminate on March 22, 2020.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. SPR
is responsible for overseeing, tracking,
and participating in the reviews of all
procedures used in the dose
reconstruction process by the NIOSH
Division of Compensation Analysis and
Support (DCAS) and its dose
reconstruction contractor (Oak Ridge
Associated Universities—ORAU).
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction
procedures: (a) Procedures associated
specifically with the following sites:
Aliquippa Forge, Hooker
Electrochemical Co., Birdsboro Steel,
Simonds Saw, Idaho National
Laboratory, General Steel Industries; (b)
general procedures for dose
reconstructions: Internal Coworker
Dosimetry Data Completeness Test,
Parameters when Processing Claims for
Construction Trade Workers. Agenda
items are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00195 Filed 1–25–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on
February 27, 2019, 11:00 a.m. to 1:00
p.m. EST.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537; the
passcode is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road NE, Mailstop E–20,
Atlanta, Georgia 30329, Telephone (513)
533–6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
SUMMARY:
E:\FR\FM\28JAN1.SGM
28JAN1
amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Notices
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
rechartered under Executive Order
13811 on February 12, 2018, and will
terminate on March 22, 2020.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Considered: The agenda
will include discussions on: Recording
December 2018 Meeting Absentee Votes;
Work Group and Subcommittee Reports;
Update on the Status of SEC Petitions;
Plans for the April 2019 Advisory Board
Meeting; and Advisory Board
Correspondence. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–00196 Filed 1–25–19; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
16:01 Jan 25, 2019
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Committee on Immunization Practices
(ACIP). This meeting is open to the
public, limited only by room seating.
The meeting room accommodates 216
for public seating. Rooms 245, 246, and
247, adjacent to the meeting room, will
be available once the meeting room
reaches capacity, providing up to 120
additional seats. Time will be available
for public comment. The meeting will
be webcast live via the World Wide
Web; for instructions and more
information on ACIP please visit the
ACIP website: https://www.cdc.gov/
vaccines/acip/.
DATES: The meeting will be held on
February 27, 2019, 8:00 a.m. to 5:30
p.m., EST, and February 28, 2019, 8:30
a.m. to 3:30 p.m. EST.
ADDRESSES: CDC, 1600 Clifton Road,
NE, Tom Harkin Global
Communications Center, Building 19,
Kent ‘Oz’ Nelson Auditorium, Atlanta,
Georgia 30329–4027.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee
Management Specialist, CDC, NCIRD,
telephone 404–639–8836, email ACIP@
cdc.gov.
SUMMARY:
SUPPLEMENTARY INFORMATION:
Purpose: The committee is charged
with advising the Director, CDC, on the
use of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is
mandated to establish and periodically
review and, as appropriate, revise the
list of vaccines for administration to
vaccine-eligible children through the
Vaccines for Children (VFC) program,
along with schedules regarding dosing
interval, dosage, and contraindications
to administration of vaccines. Further,
under provisions of the Affordable Care
Act, section 2713 of the Public Health
Service Act, immunization
recommendations of the ACIP that have
been approved by the Director of the
Centers for Disease Control and
Prevention and appear on CDC
PO 00000
Frm 00017
Fmt 4703
Sfmt 4703
427
immunization schedules must be
covered by applicable health plans.
Public Comment
Oral Public Comment: This meeting
will include one 75-minute session for
oral public comment during which
members of the public may make an inperson public comment. The oral public
comment session will occur near the
end of the first day’s session on
February 27, 2019 and before any
scheduled votes including all votes
relevant to the ACIP’s Affordable Care
Act and Vaccines for Children Program
roles. Priority will be given to
individuals who submit a request to
make an oral public comment before the
meeting according to the procedures
below. On-site, in-person registration for
oral public comment at the meeting will
only be available if there is time
remaining in the oral public comment
session after all individuals who
submitted a request to make an oral
comment before the meeting have had
an opportunity to speak. There is no
guarantee there will be an opportunity
for on-site, in-person registration for
oral public comment, and all
individuals interested in requesting to
make an oral public comment are
strongly encouraged to submit a request
according to the instructions below.
Procedure for Oral Public Comment:
All persons interested in making an oral
public comment at the February ACIP
meeting must submit a request at https://
www.cdc.gov/vaccines/acip/meetings/
no later than 11:59 p.m., EDT, February
13, 2019. Interested persons must
include their name; the name of the
group or organization the individual is
representing, if applicable; and contact
information, including email address,
mailing address, and telephone number.
If the number of persons requesting to
speak is greater than can be reasonably
accommodated during the scheduled
75-minute oral public comment session,
CDC will conduct a lottery to determine
the speakers for the scheduled session.
CDC staff will notify individuals
regarding their request to speak by email
by February 15, 2019. To accommodate
the significant interest in participation
in the oral public comment session of
ACIP meetings, each speaker will be
limited to 3 minutes, and each speaker
may only speak once per meeting.
Interested persons who are unable to
make an oral public comment during
this meeting are invited to submit a
written comment according to the
instructions below.
Written Public Comment: Written
comments will be accepted up to 48
hours following the end of the ACIP
Meeting. You may submit comments,
E:\FR\FM\28JAN1.SGM
28JAN1
Agencies
[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Notices]
[Pages 426-427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00196]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), National Institute for Occupational Safety and Health
(NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
a public comment period. The public is welcome to submit written
comments in advance of the meeting, to the contact person below.
Written comments received in advance of the meeting will be included in
the official record of the meeting. The public is also welcome to
listen to the meeting by joining the audio conference (information
below). The audio conference line has 150 ports for callers.
DATES: The meeting will be held on February 27, 2019, 11:00 a.m. to
1:00 p.m. EST.
ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537; the passcode is 9933701.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road NE, Mailstop E-20, Atlanta,
Georgia 30329, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of
[[Page 427]]
probability of causation guidelines which have been promulgated by the
Department of Health and Human Services (HHS) as a final rule, advice
on methods of dose reconstruction which have also been promulgated by
HHS as a final rule, advice on the scientific validity and quality of
dose estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes of
workers to the Special Exposure Cohort (SEC). In December 2000, the
President delegated responsibility for funding, staffing, and operating
the Advisory Board to HHS, which subsequently delegated this authority
to the CDC. NIOSH implements this responsibility for CDC. The charter
was issued on August 3, 2001, renewed at appropriate intervals,
rechartered under Executive Order 13811 on February 12, 2018, and will
terminate on March 22, 2020.
Purpose: This Advisory Board is charged with (a) providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advising the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Considered: The agenda will include discussions on:
Recording December 2018 Meeting Absentee Votes; Work Group and
Subcommittee Reports; Update on the Status of SEC Petitions; Plans for
the April 2019 Advisory Board Meeting; and Advisory Board
Correspondence. Agenda items are subject to change as priorities
dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00196 Filed 1-25-19; 8:45 am]
BILLING CODE 4163-19-P